To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Vol:255 Issue:3 Number:35 ISSN#:2564-2537
DOWNLOAD ESPAÑOL
Meta-Analysis
ACE Report #14726
Ace Report Cover Spine

COA 2022: Surgical Resection Type and Adjuvant Therapies on Survival of Primary Spine Sarcomas


How to Cite

OrthoEvidence. COA 2022: Surgical Resection Type and Adjuvant Therapies on Survival of Primary Spine Sarcomas. ACE Report. 2022;255(3):35. Available from: https://myorthoevidence.com/AceReport/Report/14726

Study Type:Meta analysis
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Primary sarcomas of the spine: a systematic review and pooled data

Contributing Authors:
P Kooner J Gaffar M Rizkallah R Turcotte A Aoude

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CONFERENCE ACE REPORTS

This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

Synopsis

Eleven studies including 150 spinal sarcoma patients were included in this meta-analysis assessing the effect of surgical resection types and adjuvant therapies on patient survival. The outcomes of interest included overall mortality/survival and local recurrence. Significantly greater overall survival was observed with en-bloc resection vs. piecemeal resection for spine chondrosarcomas and Ewing ...

Ace Report Preview Image
CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE
For Reprints and Permissions, click here

Please Login or Join to leave comments.